Affinergy has announced that veteran orthopedic expert Terry Schlotterback has joined its Board of Directors. For 20 years, Schlotterback lent his guidance to Zimmer, most recently in two key leadership roles as President of Zimmer Trauma Division and President of Zimmer Spine Division. He was also VP at Zimmer in Sales, Product Development, and Global Marketing Services roles as well as leadership roles at DePuy and Mitek Surgical Products, divisions of Johnson and Johnson.
“Affinergy’s robust product pipeline and compelling vision for growth gives me great enthusiasm to actively support this drive to commercial success, ” said Schlotterback in the news release. “These products can improve patient outcomes while simultaneously containing healthcare costs. I am confident that surgeons will be eager to incorporate these proprietary products into their practices and distributors will find them to be valuable additions to their offerings.”
“Terry has a unique combination of experiences across orthopedic markets as well as across functional areas such as product development, sales, and executive leadership, ” added Peyton Anderson, CEO of Affinergy. “He has already proven to be a tremendous advisor in terms of our product development and hiring plans for the Affinergy commercialization team. Terry’s expertise and deep industry connections will be critical to our long-term growth plans. On a personal level, Terry is a thoughtful mentor with impeccable integrity who is deeply committed to improving patient outcomes.”
Terry Schlotterback told OTW,
I am very excited about joining the Board of Directors of Affinergy. My experience in large and small companies allows a broad perspective on the challenges we face when commercializing a new product into the orthopedic market place. My years of developing new products and working closely with the distribution channels will be a benefit to Affinergy as we prepare to launch products into this space. I will draw upon my experience with Mitek Surgical Products; as a start up company we introduced new products while building a distribution channel. At Zimmer I led the Spinal Division while introducing an innovative approach to spinal fusions and building a strong distribution channel. I believe these experiences will be a benefit to Affinergy as the company prepares for commercialization of their new product.
